Lanthanide-doped upconversion nanocrystals for deep-tissue imaging

The 16th International Symposium on Applied Bioinorganic Chemistry (ISABC) brought researchers to Ioannina, Greece, in June 2023, with the University of Ioannina as organiser. Its programme addressed how inorganic systems can solve biological problems across imaging, therapeutics, environmental science and catalysis.

A central example was lanthanide-doped upconversion nanocrystals for deep-tissue imaging. These materials absorb near-infrared light and emit higher-energy visible photons through a multi-electron process called upconversion, opening a route to optical measurements beneath the skin.

For an Australian audience, the subject connects laboratory chemistry with hospital imaging, biomedical manufacturing and national research funding. It also reflects ISABC’s broader emphasis on shared methods, reproducibility and early-stage validation rather than treating a promising material as a finished diagnostic.

Why upconversion changes the imaging window

Conventional fluorescent probes are usually excited with visible light, where haemoglobin, melanin and tissue autofluorescence create strong backgrounds. Near-infrared pumping reduces this interference; the nanocrystal then converts that excitation into an anti-Stokes visible signal at the detector.

A practical comparison shows how this differs from established imaging platforms:

Platform Excitation and detection Deep-tissue advantage Main constraint
Organic fluorescent dyes Visible excitation and visible emission Simple, established workflows Autofluorescence, photobleaching and shallow penetration
Conventional quantum dots Visible excitation and bright visible emission High brightness and photostability High-energy excitation and potential toxic-metal burden
PET Radiotracer and annihilation-photon detection Quantitative measurements from deep tissue Radiation, cost and specialised infrastructure
Lanthanide-doped upconversion nanocrystals Near-infrared pump and upconverted emission Reduced autofluorescence and access to thicker tissue Conversion efficiency, heating and biological validation

Upconversion is therefore more than a method for producing brighter fluorescence. It changes excitation energy, background rejection and the amount of tissue that can be probed, although each benefit must be demonstrated in the intended biological setting.

Designing nanocrystals for biological use

A common platform uses a crystalline host such as β-NaYF₄ with sensitiser and activator ions. Yb³⁺ efficiently absorbs 980 nm light, while Er³⁺ or Tm³⁺ generates visible or near-infrared emission through energy transfer and multiphonon relaxation.

Particle size, phase, surface ligands and dopant concentration determine brightness, colloid stability and cellular uptake. A team may optimise the same suspension for a microscope and then discover that aggregation in culture medium removes much of the apparent gain.

Reproducible studies should report quantum yield under the actual excitation source, hydrodynamic size, zeta potential, residual ligands, dose and signal-to-background ratio. These details are especially important when comparing a hand-prepared batch with material made by a contract manufacturer.

Moving from optical promise to biological proof

Deep-tissue claims require layered evidence: optical phantom performance, then cells and organoids, followed by suitable animal models and eventually human studies. Signal depth should be defined with tissue attenuation, depth-resolved measurements and realistic illumination rather than inferred from a single bright image.

Safety is equally specific. Researchers must distinguish the nanocrystal from its coating, examine biodistribution, clearance and long-term toxicity, and determine whether the synthesis leaves elemental or solvent residues. Scale-up must also keep dopant distribution and surface chemistry consistent.

ISABC connected this translational mindset with other applied bioinorganic programmes, including clinical trial evidence for ruthenium-based anticancer complexes. The comparison is useful: progress depends on matched potency, pharmacokinetics and toxicity data, not simply a novel coordination structure.

Australian routes for translation and partnership

Australia offers credible routes to develop this work. Melbourne’s Parkville and Clayton biomedical clusters connect chemists, imaging scientists, clinicians and engineers, while Sydney’s Westmead precinct links hospitals with universities and medical-research institutes. Queensland adds strong centres in Brisbane and Townsville, creating partnerships that can test imaging across different climates and populations.

Australian research culture is refreshingly direct. A postgrad may ask whether a signal is “actually useful in tissue,” while collaborators expect a grant application or paper to state the reproducibility plan in plain English. That practical tone is valuable when a new material must satisfy imaging specialists, clinicians and funding reviewers.

Commercial pathways run through the Therapeutic Goods Administration, state health services, private imaging providers and biomedical companies, while NHMRC and ARC programs fund the evidence needed between discovery and adoption. Australia’s intense sunlight and high UV also reward spectral selectivity for outdoor, agricultural and wearable imaging, although biomedical claims still require controlled tissue studies.

Australian strengths and routes to adoption

Research and clinical strengths

Funding and commercial routes

Connect with the ISABC symposium community

The official ISABC welcome invited students, early-career researchers and established groups working across applied bioinorganic chemistry. For teams studying lanthanide-enabled imaging, the Ioannina meeting provided an opportunity to compare biological performance, discuss analytical methods and build links beyond their home institutions.

Symposium materials also provided information about young scientist travel awards, poster prizes, scholarships and application requirements. These schemes can widen access to the meeting and recognise work that connects molecular design with a demonstrable biological application.

Visit the official symposium resources to review participation, award and application guidance. Registration, accommodation and abstract-related inquiries are directed to Zita Congress & Event Management, the official symposium secretariat, helping teams organise a complete visit to Ioannina and share their next lanthanide-enabled imaging results.